Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Although Model 3 exhibited a lower HR for cerebrovascular disease compared to Model 2 and Model 1, the association did not reach statistical significance (HR = 0.55, 95% CI: 0.28–1.06, p = 0.076, Table 2 ). 3.4 Sensitivity Analysis To account for potential adverse effects following IFN‐based therapy, a sensitivity analysis was conducted by excluding CVD events that occurred within the first year after antiviral therapy.

also in 111,027 other papers